 | • レポートコード：MRC2-11QY04601 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は短腸症候群のグローバル市場について調査・分析したレポートです。種類別（GLP-2、成長ホルモン、グルタミン、その他）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別短腸症候群の競争状況、市場シェア ・世界の短腸症候群市場：種類別市場規模 2015年-2020年（GLP-2、成長ホルモン、グルタミン、その他） ・世界の短腸症候群市場：種類別市場規模予測 2021年-2026年（GLP-2、成長ホルモン、グルタミン、その他） ・世界の短腸症候群市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界の短腸症候群市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米の短腸症候群市場分析：米国、カナダ ・ヨーロッパの短腸症候群市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの短腸症候群市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の短腸症候群市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの短腸症候群市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Takeda、Merck、Emmaus Life Sciences、Nutrinia、GlyPharma Therapeutics、OxThera、Ardelyx、Sancilio & Company、Naia Pharmaceuticals、Zealand Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.
The medications prescribed for the treatment of SBS include teduglutide and growth hormones (aid in intestinal absorption), proton pump inhibitors (used to treat gastric acid secretions), and anti-diarrheal (to treat the primary symptom of SBS, i.e., diarrhea). As the patients with SBS have lost major part of the intestine, retaining nutrients in such patients through oral nutrition becomes difficult. Hence parenteral nutrition is the preferred mode of treatment in these patients.
Market Analysis and Insights: Global Short Bowel Syndrome Market
The global Short Bowel Syndrome market size is projected to reach US$ 524.6 million by 2026, from US$ 444.2 million in 2020, at a CAGR of 17.2%% during 2021-2026.
Global Short Bowel Syndrome Scope and Market Size
Short Bowel Syndrome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Short Bowel Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Takeda
Merck
Emmaus Life Sciences
Nutrinia
GlyPharma Therapeutics
OxThera
Ardelyx
Sancilio & Company
Naia Pharmaceuticals
Zealand Pharma
Market segment by Type, the product can be split into
GLP-2
Growth Hormone
Glutamine
Others
Market segment by Application, split into
Hospitals
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Short Bowel Syndrome Revenue
1.4 Market by Type
1.4.1 Global Short Bowel Syndrome Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 GLP-2
1.4.3 Growth Hormone
1.4.4 Glutamine
1.4.5 Others
1.5 Market by Application
1.5.1 Global Short Bowel Syndrome Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Short Bowel Syndrome Market Perspective (2015-2026)
2.2 Global Short Bowel Syndrome Growth Trends by Regions
2.2.1 Short Bowel Syndrome Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Short Bowel Syndrome Historic Market Share by Regions (2015-2020)
2.2.3 Short Bowel Syndrome Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Short Bowel Syndrome Market Growth Strategy
2.3.6 Primary Interviews with Key Short Bowel Syndrome Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Short Bowel Syndrome Players by Market Size
3.1.1 Global Top Short Bowel Syndrome Players by Revenue (2015-2020)
3.1.2 Global Short Bowel Syndrome Revenue Market Share by Players (2015-2020)
3.1.3 Global Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Short Bowel Syndrome Market Concentration Ratio
3.2.1 Global Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Short Bowel Syndrome Revenue in 2019
3.3 Short Bowel Syndrome Key Players Head office and Area Served
3.4 Key Players Short Bowel Syndrome Product Solution and Service
3.5 Date of Enter into Short Bowel Syndrome Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Short Bowel Syndrome Historic Market Size by Type (2015-2020)
4.2 Global Short Bowel Syndrome Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Short Bowel Syndrome Market Size by Application (2015-2020)
5.2 Global Short Bowel Syndrome Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Short Bowel Syndrome Market Size (2015-2020)
6.2 Short Bowel Syndrome Key Players in North America (2019-2020)
6.3 North America Short Bowel Syndrome Market Size by Type (2015-2020)
6.4 North America Short Bowel Syndrome Market Size by Application (2015-2020)
7 Europe
7.1 Europe Short Bowel Syndrome Market Size (2015-2020)
7.2 Short Bowel Syndrome Key Players in Europe (2019-2020)
7.3 Europe Short Bowel Syndrome Market Size by Type (2015-2020)
7.4 Europe Short Bowel Syndrome Market Size by Application (2015-2020)
8 China
8.1 China Short Bowel Syndrome Market Size (2015-2020)
8.2 Short Bowel Syndrome Key Players in China (2019-2020)
8.3 China Short Bowel Syndrome Market Size by Type (2015-2020)
8.4 China Short Bowel Syndrome Market Size by Application (2015-2020)
9 Japan
9.1 Japan Short Bowel Syndrome Market Size (2015-2020)
9.2 Short Bowel Syndrome Key Players in Japan (2019-2020)
9.3 Japan Short Bowel Syndrome Market Size by Type (2015-2020)
9.4 Japan Short Bowel Syndrome Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Short Bowel Syndrome Market Size (2015-2020)
10.2 Short Bowel Syndrome Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Short Bowel Syndrome Market Size by Type (2015-2020)
10.4 Southeast Asia Short Bowel Syndrome Market Size by Application (2015-2020)
11 India
11.1 India Short Bowel Syndrome Market Size (2015-2020)
11.2 Short Bowel Syndrome Key Players in India (2019-2020)
11.3 India Short Bowel Syndrome Market Size by Type (2015-2020)
11.4 India Short Bowel Syndrome Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Short Bowel Syndrome Market Size (2015-2020)
12.2 Short Bowel Syndrome Key Players in Central & South America (2019-2020)
12.3 Central & South America Short Bowel Syndrome Market Size by Type (2015-2020)
12.4 Central & South America Short Bowel Syndrome Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Takeda
13.1.1 Takeda Company Details
13.1.2 Takeda Business Overview
13.1.3 Takeda Short Bowel Syndrome Introduction
13.1.4 Takeda Revenue in Short Bowel Syndrome Business (2015-2020))
13.1.5 Takeda Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Short Bowel Syndrome Introduction
13.2.4 Merck Revenue in Short Bowel Syndrome Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Emmaus Life Sciences
13.3.1 Emmaus Life Sciences Company Details
13.3.2 Emmaus Life Sciences Business Overview
13.3.3 Emmaus Life Sciences Short Bowel Syndrome Introduction
13.3.4 Emmaus Life Sciences Revenue in Short Bowel Syndrome Business (2015-2020)
13.3.5 Emmaus Life Sciences Recent Development
13.4 Nutrinia
13.4.1 Nutrinia Company Details
13.4.2 Nutrinia Business Overview
13.4.3 Nutrinia Short Bowel Syndrome Introduction
13.4.4 Nutrinia Revenue in Short Bowel Syndrome Business (2015-2020)
13.4.5 Nutrinia Recent Development
13.5 GlyPharma Therapeutics
13.5.1 GlyPharma Therapeutics Company Details
13.5.2 GlyPharma Therapeutics Business Overview
13.5.3 GlyPharma Therapeutics Short Bowel Syndrome Introduction
13.5.4 GlyPharma Therapeutics Revenue in Short Bowel Syndrome Business (2015-2020)
13.5.5 GlyPharma Therapeutics Recent Development
13.6 OxThera
13.6.1 OxThera Company Details
13.6.2 OxThera Business Overview
13.6.3 OxThera Short Bowel Syndrome Introduction
13.6.4 OxThera Revenue in Short Bowel Syndrome Business (2015-2020)
13.6.5 OxThera Recent Development
13.7 Ardelyx
13.7.1 Ardelyx Company Details
13.7.2 Ardelyx Business Overview
13.7.3 Ardelyx Short Bowel Syndrome Introduction
13.7.4 Ardelyx Revenue in Short Bowel Syndrome Business (2015-2020)
13.7.5 Ardelyx Recent Development
13.8 Sancilio & Company
13.8.1 Sancilio & Company Company Details
13.8.2 Sancilio & Company Business Overview
13.8.3 Sancilio & Company Short Bowel Syndrome Introduction
13.8.4 Sancilio & Company Revenue in Short Bowel Syndrome Business (2015-2020)
13.8.5 Sancilio & Company Recent Development
13.9 Naia Pharmaceuticals
13.9.1 Naia Pharmaceuticals Company Details
13.9.2 Naia Pharmaceuticals Business Overview
13.9.3 Naia Pharmaceuticals Short Bowel Syndrome Introduction
13.9.4 Naia Pharmaceuticals Revenue in Short Bowel Syndrome Business (2015-2020)
13.9.5 Naia Pharmaceuticals Recent Development
13.10 Zealand Pharma
13.10.1 Zealand Pharma Company Details
13.10.2 Zealand Pharma Business Overview
13.10.3 Zealand Pharma Short Bowel Syndrome Introduction
13.10.4 Zealand Pharma Revenue in Short Bowel Syndrome Business (2015-2020)
13.10.5 Zealand Pharma Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Short Bowel Syndrome Key Market Segments
Table 2. Key Players Covered: Ranking by Short Bowel Syndrome Revenue
Table 3. Ranking of Global Top Short Bowel Syndrome Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Short Bowel Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of GLP-2
Table 6. Key Players of Growth Hormone
Table 7. Key Players of Glutamine
Table 8. Key Players of Others
Table 9. Global Short Bowel Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Short Bowel Syndrome Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Short Bowel Syndrome Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Short Bowel Syndrome Market Share by Regions (2015-2020)
Table 13. Global Short Bowel Syndrome Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Short Bowel Syndrome Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Short Bowel Syndrome Market Growth Strategy
Table 19. Main Points Interviewed from Key Short Bowel Syndrome Players
Table 20. Global Short Bowel Syndrome Revenue by Players (2015-2020) (Million US$)
Table 21. Global Short Bowel Syndrome Market Share by Players (2015-2020)
Table 22. Global Top Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome as of 2019)
Table 23. Global Short Bowel Syndrome by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Short Bowel Syndrome Product Solution and Service
Table 26. Date of Enter into Short Bowel Syndrome Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 29. Global Short Bowel Syndrome Market Size Share by Type (2015-2020)
Table 30. Global Short Bowel Syndrome Revenue Market Share by Type (2021-2026)
Table 31. Global Short Bowel Syndrome Market Size Share by Application (2015-2020)
Table 32. Global Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 33. Global Short Bowel Syndrome Market Size Share by Application (2021-2026)
Table 34. North America Key Players Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Short Bowel Syndrome Market Share (2019-2020)
Table 36. North America Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 37. North America Short Bowel Syndrome Market Share by Type (2015-2020)
Table 38. North America Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 39. North America Short Bowel Syndrome Market Share by Application (2015-2020)
Table 40. Europe Key Players Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Short Bowel Syndrome Market Share (2019-2020)
Table 42. Europe Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Short Bowel Syndrome Market Share by Type (2015-2020)
Table 44. Europe Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Short Bowel Syndrome Market Share by Application (2015-2020)
Table 46. China Key Players Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 47. China Key Players Short Bowel Syndrome Market Share (2019-2020)
Table 48. China Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 49. China Short Bowel Syndrome Market Share by Type (2015-2020)
Table 50. China Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 51. China Short Bowel Syndrome Market Share by Application (2015-2020)
Table 52. Japan Key Players Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Short Bowel Syndrome Market Share (2019-2020)
Table 54. Japan Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Short Bowel Syndrome Market Share by Type (2015-2020)
Table 56. Japan Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Short Bowel Syndrome Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Short Bowel Syndrome Market Share (2019-2020)
Table 60. Southeast Asia Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Short Bowel Syndrome Market Share by Type (2015-2020)
Table 62. Southeast Asia Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Short Bowel Syndrome Market Share by Application (2015-2020)
Table 64. India Key Players Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 65. India Key Players Short Bowel Syndrome Market Share (2019-2020)
Table 66. India Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 67. India Short Bowel Syndrome Market Share by Type (2015-2020)
Table 68. India Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 69. India Short Bowel Syndrome Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Short Bowel Syndrome Market Share (2019-2020)
Table 72. Central & South America Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Short Bowel Syndrome Market Share by Type (2015-2020)
Table 74. Central & South America Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Short Bowel Syndrome Market Share by Application (2015-2020)
Table 76. Takeda Company Details
Table 77. Takeda Business Overview
Table 78. Takeda Product
Table 79. Takeda Revenue in Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 80. Takeda Recent Development
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Product
Table 84. Merck Revenue in Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 85. Merck Recent Development
Table 86. Emmaus Life Sciences Company Details
Table 87. Emmaus Life Sciences Business Overview
Table 88. Emmaus Life Sciences Product
Table 89. Emmaus Life Sciences Revenue in Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 90. Emmaus Life Sciences Recent Development
Table 91. Nutrinia Company Details
Table 92. Nutrinia Business Overview
Table 93. Nutrinia Product
Table 94. Nutrinia Revenue in Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 95. Nutrinia Recent Development
Table 96. GlyPharma Therapeutics Company Details
Table 97. GlyPharma Therapeutics Business Overview
Table 98. GlyPharma Therapeutics Product
Table 99. GlyPharma Therapeutics Revenue in Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 100. GlyPharma Therapeutics Recent Development
Table 101. OxThera Company Details
Table 102. OxThera Business Overview
Table 103. OxThera Product
Table 104. OxThera Revenue in Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 105. OxThera Recent Development
Table 106. Ardelyx Company Details
Table 107. Ardelyx Business Overview
Table 108. Ardelyx Product
Table 109. Ardelyx Revenue in Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 110. Ardelyx Recent Development
Table 111. Sancilio & Company Business Overview
Table 112. Sancilio & Company Product
Table 113. Sancilio & Company Company Details
Table 114. Sancilio & Company Revenue in Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 115. Sancilio & Company Recent Development
Table 116. Naia Pharmaceuticals Company Details
Table 117. Naia Pharmaceuticals Business Overview
Table 118. Naia Pharmaceuticals Product
Table 119. Naia Pharmaceuticals Revenue in Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 120. Naia Pharmaceuticals Recent Development
Table 121. Zealand Pharma Company Details
Table 122. Zealand Pharma Business Overview
Table 123. Zealand Pharma Product
Table 124. Zealand Pharma Revenue in Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 125. Zealand Pharma Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Short Bowel Syndrome Market Share by Type: 2020 VS 2026
Figure 2. GLP-2 Features
Figure 3. Growth Hormone Features
Figure 4. Glutamine Features
Figure 5. Others Features
Figure 6. Global Short Bowel Syndrome Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Short Bowel Syndrome Report Years Considered
Figure 10. Global Short Bowel Syndrome Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Short Bowel Syndrome Market Share by Regions: 2020 VS 2026
Figure 12. Global Short Bowel Syndrome Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Short Bowel Syndrome Market Share by Players in 2019
Figure 15. Global Top Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Short Bowel Syndrome Revenue in 2019
Figure 17. North America Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
短腸症候群（SBS）の世界市場（～2026年） Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…- 短腸症候群（SBS）治療薬の世界市場（～2026年） Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…
- 炎症性腸疾患（IBD）治療の世界市場（～2026年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…
- 炎症性腸疾患（IBD）の世界市場（～2026年） Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stom…
- 腸管理システムの世界市場（～2026年） Bowel management is the process which a person with a bowel disability uses to manage fecal incontinence or constipation. People who have a medical condition which impairs control of their defecation use bowel management techniques to choose a predictable time and place to evacuate. A simple bowel m…